|
|
|||||||||
Basic science investigations |
1 Department of Radiation Physics, Sahlgrenska University Hospital, Göteborgs Universitet, Göteborg, Sweden
2 Institute of Anatomy and Cell Biology, Göteborgs Universitet, Göteborg, Sweden
3 Department of Oncology, Sahlgrenska University Hospital, Göteborgs Universitet, Göteborg, Sweden
4 Department of Surgery, Sahlgrenska University Hospital, Göteborgs Universitet, Göteborg, Sweden
5 Department of Internal Medicine, Sahlgrenska University Hospital, Göteborgs Universitet, Göteborg, Sweden
The existence of thyroid stunning (i.e., inhibited thyroidal iodide uptake after administration of diagnostic amounts of 131I) is controversial and is currently a subject of debate. To our knowledge, the stunning phenomenon has not been investigated previously in vitro. Methods: Growth-arrested porcine thyroid cells that formed a tight and polarized monolayer in a bicameral chamber were irradiated with 380 Gy 131I present in the surrounding culture medium for 48 h. The iodide transport capacity after irradiation was evaluated 3 d later by measuring the transepithelial (basal to apical) flux of trace amounts of 125I. Results: The basal-to-apical 125I transport decreased with increasing absorbed dose acquired from 131I; a nearly 50% reduction was observed already at 3 Gy. Stable iodide at the same molarity as 131I (10-8 mol/L) had no effect on the 125I transport. Cell number and epithelial integrity were not affected by irradiation. Conclusion: Stunning of iodide transport is detected after 131I irradiation of cultured thyroid cells. The degree of inhibition of transport is dependent on the absorbed dose.
Key Words: radioiodide stunning thyroid 131I
This article has been cited by other articles:
![]() |
C. Lundh, U. Lindencrona, P. Postgard, T. Carlsson, M. Nilsson, and E. Forssell-Aronsson Radiation-Induced Thyroid Stunning: Differential Effects of 123I, 131I, 99mTc, and 211At on Iodide Transport and NIS mRNA Expression in Cultured Thyroid Cells J. Nucl. Med., July 1, 2009; 50(7): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fast, V. E. Nielsen, S. J. Bonnema, and L. Hegedus Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy Eur. J. Endocrinol., April 1, 2009; 160(4): 517 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Norden, F. Larsson, S. Tedelind, T. Carlsson, C. Lundh, E. Forssell-Aronsson, and M. Nilsson Down-regulation of the Sodium/Iodide Symporter Explains 131I-Induced Thyroid Stunning Cancer Res., August 1, 2007; 67(15): 7512 - 7517. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lundh, M. M. Norden, M. Nilsson, and E. Forssell-Aronsson Reduced Iodide Transport (Stunning) and DNA Synthesis in Thyrocytes Exposed to Low Absorbed Doses from 131I In Vitro J. Nucl. Med., March 1, 2007; 48(3): 481 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gerard and H.-M. Park Stunning Effect J. Nucl. Med., February 1, 2007; 48(2): 328 - 329. [Full Text] [PDF] |
||||
![]() |
J. M. Woolfenden Thyroid Stunning Revisited J. Nucl. Med., September 1, 2006; 47(9): 1403 - 1405. [Full Text] [PDF] |
||||
![]() |
J. C. Sisson, A. M. Avram, S. A. Lawson, P. G. Gauger, and G. M. Doherty The So-Called Stunning of Thyroid Tissue J. Nucl. Med., September 1, 2006; 47(9): 1406 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Bonnema, F. N. Bennedbaek, A. Veje, J. Marving, and L. Hegedus Continuous Methimazole Therapy and Its Effect on the Cure Rate of Hyperthyroidism Using Radioactive Iodine: An Evaluation by a Randomized Trial J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2946 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tedelind, F. Larsson, C. Johanson, H. C. van Beeren, W. M. Wiersinga, E. Nystrom, and M. Nilsson Amiodarone Inhibits Thyroidal Iodide Transport in Vitro by a Cyclic Adenosine 5'-Monophosphate- and Iodine-Independent Mechanism Endocrinology, June 1, 2006; 147(6): 2936 - 2943. [Abstract] [Full Text] [PDF] |
||||
![]() |
A F Leger, M Pellan, F Dagousset, A Chevalier, I Keller, and J Clerc A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments Br. J. Radiol., May 1, 2005; 78(929): 428 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gerard and H. Q. Dam Stunning with 131I Diagnostic Whole-Body Imaging of Patients with Thyroid Cancer * Dr Dam responds: Radiology, March 1, 2005; 234(3): 972 - 974. [Full Text] [PDF] |
||||
![]() |
H. Q. Dam, S. M. Kim, H. C. Lin, and C. M. Intenzo 131I Therapeutic Efficacy Is Not Influenced by Stunning after Diagnostic Whole-Body Scanning Radiology, August 1, 2004; 232(2): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lassmann, M. Luster, H. Hanscheid, and C. Reiners Impact of 131I Diagnostic Activities on the Biokinetics of Thyroid Remnants J. Nucl. Med., April 1, 2004; 45(4): 619 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gerard, H. M. Park, and S. A. Gulec 131I Dosimetry and Thyroid Stunning J. Nucl. Med., December 1, 2003; 44(12): 2039 - 2040. [Full Text] [PDF] |
||||
![]() |
K. C. Allman Thyroid Stunning Revisited J. Nucl. Med., July 1, 2003; 44(7): 1194 - 1194. [Full Text] [PDF] |
||||
![]() |
W. Brenner Is Thyroid Stunning a Real Phenomenon or Just Fiction? J. Nucl. Med., June 1, 2002; 43(6): 835 - 836. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |